Device type · DGC
Ige, Antigen, Antiserum, Control
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
DGC
Immunology
Device class
Class II
FDA decisions since 2015
5
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Ige, Antigen, Antiserum, Control
- Product code
- DGC
- Device class
- Class II
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5510
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for DGC
Latest FDA decisions
K231151 · Decided May 31, 2024 · 403 days after receipt
Device type: Ige, Antigen, Antiserum, Control (DGC) · Laboratory Medicine & Pathology
- Quantia IgE510(k)
K214068 · Decided Feb 21, 2023 · 421 days after receipt
Device type: Ige, Antigen, Antiserum, Control (DGC) · Laboratory Medicine & Pathology
K220178 · Decided Mar 23, 2022 · 61 days after receipt
Device type: Ige, Antigen, Antiserum, Control (DGC) · Laboratory Medicine & Pathology
Siemens Healthcare Diagnostics, Inc.
K193493 · Decided Jan 15, 2020 · 29 days after receipt
Device type: Ige, Antigen, Antiserum, Control (DGC) · Laboratory Medicine & Pathology
K161899 · Decided Jul 28, 2016 · 17 days after receipt
Device type: Ige, Antigen, Antiserum, Control (DGC) · Laboratory Medicine & Pathology
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2097-2018 · Started Mar 5, 2018
Reason given: Asfotase Alfa (Strensiq) interferes with certain Tosoh assays which potentially causes falsely increased or falsely decreased immunoassay test results, depending upon the assay.
Cause as FDA categorized it: Device Design
- IgE Calibrator SeriesTerminated
Z-0050-2017 · Started Sep 7, 2016 · Posted by FDA Oct 6, 2016
Reason given: According to the firm, the IgE Calibrator Series IE2492 (lot 387-392IE) value assignment has now been aligned to the 3rd International Standard for human serum IgE 11/234. Turbidimetric (Non-IFCC Cal.) Quality Control Targets and Ranges now apply. The calibrator value sheet is to be updated with the new values.
Cause as FDA categorized it: Under Investigation by firm
Siemens Medical Solutions Diagnostics
Z-1399-2009 · Started Jan 5, 2009 · Posted by FDA May 26, 2009
Reason given: Design Flaw: The redesign of the Digital Fluidics PCB used in IMMULITE 2000 and IMMULITE 2500 is missing a jumper.
Cause as FDA categorized it: Process design
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.